Abstract
NAADP mediates ATP-induced
production, and Ca 2+ release from the endoplasmic reticulum, they differ in magnitude and spatialand temporal characteristics, which indicates that they are not equally capable of stimulating gliotransmitter release.
NAADP is the most recently discovered and most potent Ca 2+ mobilizing second messenger [4, 5] and has been shown to control cellular events such as insulin release from pancreatic β cells [6] or fertilization [7] . The main features of NAADP are its ability to mobilize Ca 2+ from lysosome-related acidic organelles and its bell-shaped concentration-effect curve [4, 6, 8] . NAADP is also considered as a Ca 2+ trigger signal in many cell systems. The molecular identity of NAADP receptors in mammals is still unresolved, although two-pore channels (TPC) have been demonstrated to be endogenous NAADP receptors in sea urchins and to act as NAADP-activating Ca 2+ channels when they are overexpressed in particular mammalian cell lines [9, 10] . It has also been suggested that transient receptor potentialmucolipin 1 channel (TRP-ML1), TRPM-2 and ryanodine receptors act as a NAADP-sensitive channels [10] .
Widespread distribution of NAADP binding sites in the brain [11] and glutamate-induced NAADP increases in whole-brain tissue [12] support a role for this second messenger in the brain. But to date, there is no evidence for NAADP as an intracellular second messenger in astrocytes.
Materials and Methods

Materials
[ 32 P]Nicotinamide adenine dinucleotide ([ 32 P]NAD) (800 Ci/mmol) was purchased from PerkinElmer; lysotracker red, penicillin and streptomycin from Invitrogen, and endothelin-1 (human, porcine), bafilomycin A1 and 2-aminoethoxydiphenylborane (2-APB) from Tocris. Ned-19 and NAADP-AM were synthesized in house. All other compounds were from Sigma.
Tissue Culture
Primary cultures of cortical astrocytes were prepared from 1-day-old Sprague-Dawley rats following the protocol described previously [13] . Cells were plated into 35-mm dishes containing a coverslip at a density of 0.2 x 10 6 viable cells/ml in DMEM supplemented with 10% fetal bovine serum (FBS), 50 units/ml penicillin and 50 µg/ml streptomycin. 
NAADP was synthesized in a two-step reaction as described previously [15] . To determine endogenous NAADP levels, we used a radioreceptor binding assay extensively described by us [15] .
In brief, cells cultured in 60-mm dishes were stimulated with ATP or vehicle and NAADP content of samples was quantified using a competitive binding curve made with known concentrations of NAADP. Data were normalized to calculate the fold increases over basal NAADP levels.
Results
NAADP is an intracellular second messenger in astrocytes
To study whether NAADP is an endogenous molecule in astrocytes, we first determined intracellular NAADP levels. Our data showed that at rest conditions NAADP was present at very low concentrations, 5.09 ± 0.93 pmol/mg protein ( n = 20). These results are in agreement with published results of resting NAADP levels in different tissues that range from 0.1 to 48 pmol/mg protein and particularly with resting NAADP levels detected in whole-brain cell suspensions (8.3 pmol/mg protein) [12] .
We also investigated the presence of NAADP receptors in astrocytes. As their nature is not completely and unequivocally resolved in mammalian cells and the presence of multiple binding sites for NAADP has been suggested in the brain [11] , we considered that Ned-19, a fluorescent highly selective NAADP receptor antagonist [16] , was the best tool for such studies. Figure 1 shows that Ned-19 binding sites, presumably the NAADP receptors, are present in intact astrocytes with a punctate distribution and with a very high degree of colocalization with labelling of acidic organelles with lysotracker (correlation coefficient of 0.62). It is worth noting that not all acidic vesicles stained with lysotracker express NAADP receptors, stressing the heterogeneity of these organelles.
Conversely, a very small percentage of the punctate staining of NAADP receptors did not colocalize with lysotracker, in agreement with results suggesting that the putative NAADP TPC1 partly localizes in endosomes [10] . On the other hand, lack of complete overlap demonstrate that the colocalization is not an artefact of light bleed from one channel to the other.
We then investigated whether increases in the NAADP concentration induced Ca 2+ responses by adding NAADP-AM, a cell permeable acetoxymethyl ester of NAADP, to astrocytes loaded with fura-2. NAADP-AM is a less invasive tool than micro-injection of NAADP or caged-NAADP and it has been shown to be effective in numerous mammalian cell types [17] . The addition of 50 nM or 100 nM NAADP-AM produced complex Ca 2+ responses with a prominent oscillatory component ( (Fig.2C) Figure 1SA and B) . Moreover, Ca 2+ responses induced by extracellular NAADP were not inhibited by Ned-19 in any tested culture (Fig. S1C) , demonstrating that extra-and intracellular NAADP act on different molecular targets in astrocytes.
Taken together, these results suggest that intracellular NAADP is an endogenous molecule in astrocytes able to induce Ca 2+ release by the activation of receptors present mainly in acidic lysosomerelated vesicles.
NAADP and acidic organelles mediate agonist-induced Ca 2+ responses
We next investigated whether the NAADP signalling pathway could be activated by extracellular stimuli in astrocytes. In particular, we analysed the Ca 2+ responses elicited by ATP, endothelin-1 and bradykinin, agonists traditionally linked to phospholipase C activation and IP 3 -mediated Ca 2+ release from the endoplasmic reticulum. Endothelin-1, however, has also been reported to increase NAADP levels in smooth muscle [20] .
The addition of 100 μM ATP, 10 nM endothelin-1 or 1 μM bradykinin to astrocytes elicited Ca
2+
responses characterized by an initial peak followed by a plateau phase (Fig. 3) . The latter was more sustained if induced by endothelin-1, and in all cases it was sensitive to extracellular Ca 2+ (Fig. 4) [ 21, 22] . To determine the participation of NAADP signalling, we first pre-treated the cells with 100
μM Ned-19 to block the NAADP receptor. As shown in Fig. 3A and Fig. 3B , Ned-19 reduced the initial peak of the Ca 2+ responses induced by ATP and endothelin-1, but no effect was observed on the increases elicited by bradykinin (Fig. 3C) . Similarly, osmotic lysis of the lysosome-related organelles with 50 µM GPN and Ca 2+ depletion of acidic vesicles with 2 µM bafilomycin A1 inhibited the peak phase of ATP and endothelin-1, but not bradykinin-induced, Ca 2+ responses (Fig. 3A, 3B and 3C ).
Reduction of the magnitude of ATP and endothelin-1-induced Ca 2+ responses by Ned-19 was similar to that achieved by blocking the IP 3 -mediated Ca 2+ mobilization with 100 μM 2-APB, although in this case the second phase of the responses were also inhibited (Fig. 5 ). This and the results with EGTA plotted in Fig. 4 release and capacitative Ca 2+ entry [21, 22] . On the contrary, 100 μM 8-Br-cADPR, an antagonist of the second messenger cADPR, had no statistically significant effect on the responses of ATP and endothelin-1 ( Fig. 5A and B) but partly inhibited bradykinin-induced Ca 2+ increases (Fig.   5C ).
ATP increases NAADP levels
Our results constitute the first report linking activation of purinergic receptors and Ca 2+ release from acidic organelles in mammalian cells. In order to further support our data we determined intracellular NAADP levels after stimulation with ATP. We used a sensitive radioreceptor assay with a very high degree of specificity and that excludes any interference of the added ATP [6, 15] . Fig. 6 shows that 100 μM ATP stimulated the production of NAADP over time in astrocytes, whereas no increases were detected if Krebs buffer was added (control). The ATP-mediated NAADP increase was fast and transient. These data demonstrate that NAADP is involved in the early phase of ATPinduced Ca 2+ responses.
Discussion
In this study we provide direct evidence that NAADP is a true intracellular second messenger in astrocytes. The low NAADP-AM concentrations needed to elicit a response, the bell-shaped doseeffect curve, together with the low intracellular NAADP levels and their fast and transient increase in response to purinergic stimulation, agree with the NAADP signalling characteristics described in other cell types [4, 5, 10] . Interestingly, we also showed localization of the NAADP receptors in increases after extracellular addition of NAADP to astrocytes have been reported previously [18, 19] , although in these studies Ca 2+ responses were shown at 10 M NAADP. In both reports, NAADPelicited responses were heterogeneous and mediated by multiple and different signalling mechanisms.
Moreover, Heidemann and co-workers also showed that extracellular NADP and NAAD elicited Ca 2+ responses [18] , and Singaravelu and colleagues questioned NAADP internalization in astrocytes [19] .
Taken together all the data demonstrate that extra-and intracellular NAADP act on different molecular targets in glial cells. It is worth noting that a previous report failed to detect increases in NAADP levels in response to ATP in whole brain cell suspensions [12] , probably due to the presence of cell types other than cortical astrocytes, in which ATP might not be coupled to NAADP signalling. The aforementioned work also reported that in cultures of hippocampal glial cells, bafilomycin A1 did not reduce the magnitude of ATP-induced Ca 2+ responses, [12] in contrast to our data showing a clear effect of bafilomycin A1 in ATP-mediated Ca 2+ responses in cortical astrocytes. All together, these results may underline regional diversity within the glial lineage in respect to the nature of Ca 2+ lysosomallike stores and agonist recruitment of second messengers. Indeed, there is emerging data suggesting that astrocytes are not a homogenous cell population, and that unique characteristics of astrocytes of different regions may distinctly tune the neuronal activities [23] . However, one cannot exclude that discrepancies between our data and those reported in hippocampal astrocytes could be best explained by differences in the methodology used. Whereas the experiments here were performed in physiological-like conditions, Pandley and coworkers kept cells in Ca 2+ -free medium. In such conditions lysosome-related Ca 2+ homeostasis might also be altered.
Our results uncovering new intracellular signalling pathways linked to activation of purinergic receptors in astrocytes are of notable significance as ATP not only acts a main astrocyte-to-astrocyte messenger, but also as a unique neuron-to-glia mediator [2] . Moreover, NAADP signalling pathway involvement in selective neurotransmitter-induced responses demonstrates the complexity of astrocytic Ca 2+ signalling and hence excitability. Importantly, future investigations in situ and in vivo based on our description of astrocytic NAADP signalling coupled to ATP signalling could shed light on the present debate on the role of astrocytes in synaptic transmission in vivo [24] .
In summary, we report that NAADP is an authentic intracellular second messenger in cultured astrocytes and plays an important role in ATP-mediated Ca 2+ signals. increases at 1mM NAADP.
